New hope for hepatitis c patients whose first treatment failed
NCT ID NCT05248919
Summary
This study aims to find the best second treatment for people in Pakistan whose Hepatitis C infection did not clear after their first round of antiviral drugs. It will compare two different lengths of a follow-up drug combination (12 weeks vs. 24 weeks) in about 318 adults. The goal is to determine which treatment plan is more effective at controlling the virus for those who didn't respond initially.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical trials unit
Karachi, Sindh, Pakistan
Conditions
Explore the condition pages connected to this study.